Clinical presentations, parasite genotypes, gene expression and immunological profiles of cutaneous Leishmaniasis patients in lay Gayint, Northwest Ethiopia

被引：0
|
作者：
Yizengaw, E. [1 ]
Nibret, E. [1 ]
Kropf, P. [2 ]
机构：
[1] Bahir Dar Univ, Bahir Dar, Ethiopia
[2] Imperial Coll, London, England
来源：
CLINICA CHIMICA ACTA | 2024年 / 558卷
关键词：
D O I：
10.1016/j.cca.2024.119391
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页数：1
相关论文
共 9 条
  • [1] Demographic characteristics and clinical features of patients presenting with different forms of cutaneous leishmaniasis, in Lay Gayint, Northern Ethiopia
    Yizengaw, Endalew
    Gashaw, Bizuayehu
    Yimer, Mulat
    Takele, Yegnasew
    Nibret, Endalkachew
    Yismaw, Gizachew
    Cervera, Edward Cruz
    Ejigu, Kefale
    Tamiru, Dessalegn
    Munshea, Abaineh
    Mueller, Ingrid
    Weller, Richard
    Cotton, James A.
    Chapman, Lloyd A. C.
    Kropf, Pascale
    PLOS NEGLECTED TROPICAL DISEASES, 2024, 18 (08):
  • [2] Epidemiological and clinical profiles of cutaneous leishmaniasis cases in Amhara National Regional State, Northwest Ethiopia: a multicenter retrospective study
    Gashaw, Bizuayehu
    Yizengaw, Endalew
    Nibret, Endalkachew
    Workineh, Addisu
    Abebe, Adisu
    DERMATOLOGY REPORTS, 2025, 17 (01)
  • [3] Investigation of parasite genetic variation and systemic immune responses in patients presenting with different clinical presentations of cutaneous leishmaniasis caused by Leishmania aethiopica
    Yizengaw, Endalew
    Takele, Yegnasew
    Franssen, Susanne
    Gashaw, Bizuayehu
    Yimer, Mulat
    Adem, Emebet
    Nibret, Endalkachew
    Yismaw, Gizachew
    Cervera, Edward Cruz
    Ejigu, Kefale
    Tamiru, Dessalegn
    Munshea, Abaineh
    Mueller, Ingrid
    Weller, Richard
    Cotton, James A.
    Kropf, Pascale
    INFECTIOUS DISEASES OF POVERTY, 2024, 13 (01)
  • [4] Clinical, parasitological and molecular profiles of Cutaneous Leishmaniasis and its associated factors among clinically suspected patients attending Borumeda Hospital, North-East Ethiopia
    Bisetegn, Habtye
    Zeleke, Ayalew Jejaw
    Gadisa, Endalamaw
    Shumie, Girma
    Damte, Demekech
    Fenta, Tiruework
    Behaksra, Sinkinesh
    Bayih, Abebe Genetu
    PLOS NEGLECTED TROPICAL DISEASES, 2020, 14 (08): : 1 - 13
  • [5] Integrated analysis of high- resolution DNA methylation profiles, gene expression, germline genotypes and clinical end points in breast cancer patients
    Fleischer, Thomas
    Edvardsen, Hege
    Solvang, Hiroko K.
    Daviaud, Christian
    Naume, Bjorn
    Borresen-Dale, Anne-Lise
    Kristensen, Vessela N.
    Tost, Joerg
    INTERNATIONAL JOURNAL OF CANCER, 2014, 134 (11) : 2615 - 2625
  • [6] Association of gene expression profiles and clinical outcomes in patients with locally advanced or recurrent/metastatic cutaneous squamous cell carcinoma treated with pembrolizumab in KEYNOTE-629
    Bratland, Ase
    Grob, Jean-Jacques
    Couselo, Eva Munoz
    Mortier, Laurent
    Gutzmer, Ralf
    Roshdy, Osama
    Gonzalez, Rene Mendoza
    Schachter, Jacob
    Fernandez, Ana M. Arance
    Grange, Florent
    Meyer, Nicolas
    Joshi, Abhishek J.
    Billan, Salem
    Shen, Judong
    Cristescu, Razvan
    Nebozhyn, Michael
    Loboda, Andrey
    Sparkowski, Jason
    Gumuscu, Burak
    Yuan, Jianda
    Hughes, Brett
    CANCER RESEARCH, 2024, 84 (07)
  • [7] Oral LBH589, a novel histone deacetylase inhibitor, treatment of patients with cutaneous T-cell lymphoma (CTCL). Changes in skin gene expression profiles related to clinical response following therapy
    Prince, H. Miles
    Ellis, Leigh
    Johnstone, Ricky
    McCormack, Christopher
    McArthur, Grant
    Davison, Jill
    Atadja, Peter W.
    Kwong, Celena
    Dugan, Margaret
    Culver, Kenneth W.
    CANCER RESEARCH, 2006, 66 (08)
  • [8] LBH589, a novel histone deacetylase inhibitor (HDACi), treatment of patients with cutaneous T-cell lymphoma (CTCL). Changes in skin gene expression profiles related to clinical response following therapy.
    Prince, H. M.
    George, D. J.
    Johnstone, R.
    Williams-Truax, R.
    Atadja, P.
    Zhao, C.
    Dugan, M.
    Culver, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 422S - 422S
  • [9] LBH589, a novel deacetylase inhibitor (DACi), treatment of patients with cutaneous T-cell lymphoma (CTCL). Skin gene expression profiles in the first 24 hours related to clinical response following therapy.
    Prince, Miles
    George, D. J.
    Johnstone, R.
    McCormack, C.
    Ellis, L.
    Williams-Truax, R.
    Atadja, P.
    Zhao, C.
    Dugan, M.
    Culver, K.
    BLOOD, 2006, 108 (11) : 767A - 767A
1